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ABSTRACT
The placenta is important in providing a healthy environment for the fetus and plays a central role
in the pathophysiology of preeclampsia (PE). Fetal and placental developments are influenced by
epigenetic programming. There is some evidence that PE is controlled to an altered circadian
homeostasis. In a nested case–control study embedded in the Rotterdam Periconceptional Cohort,
we obtained placental tissue, umbilical cord leukocytes (UCL), and human umbilical venous
endothelial cells of 13 early-onset PE, 16 late-onset PE and 83 controls comprising 36 uncompli-
cated and 47 complicated pregnancies, i.e. 27 fetal growth restricted and 20 spontaneous preterm
birth. To investigate the associations between PE and the epigenetics of circadian clock and clock-
controlled genes in placental and newborn tissues, genome-wide DNA methylation analysis was
performed using the Illumina HumanMethylation450K BeadChip and a candidate-gene approach
using ANCOVA was applied on 939 CpGs of 39 circadian clock and clock-controlled genes. DNA
methylation significantly differed in early-onset PE compared with spontaneous preterm birth at 6
CpGs in placental tissue (3.73E-5 ≤ p ≤ 0.016) and at 21 CpGs in UCL (1.09E-5≤ p ≤ 0.024). In early-
onset PE compared with fetal growth restriction 2 CpGs in placental tissue (p < 0.05) and 8 CpGs
in uncomplicated controls (4.78E-5≤ p ≤ 0.049) were significantly different. Moreover, significantly
different DNA methylation in early-onset PE compared with uncomplicated controls was shown at
6 CpGs in placental tissue (1.36E-4≤ p ≤ 0.045) and 11 CpGs in uncomplicated controls (2.52E-6≤ p ≤
0.009). No significant associations were shown with late-onset PE between study groups or tissues.
The most differentially methylated CpGs showed hypomethylation in placental tissue and hyper-
methylation in uncomplicated controls. In conclusion, DNA methylation of circadian clock and
clock-controlled genes demonstrated most differences in UCL of early-onset PE compared with
spontaneous preterm birth. Implications of the tissue-specific variations in epigenetic program-











The placenta serves as the maternal–fetal interface
during pregnancy and is one of the main determi-
nants of pregnancy course and outcome. It also
functions as an endocrine organ and plays a major
role in maternal adaptation to pregnancy and fetal
growth and development (Burton & Jauniaux,
2015; Burton et al., 2016). Preeclampsia (PE) is a
multiorgan disorder in which impaired placental
functioning due to excessive oxidative stress is
involved (Steegers et al., 2010). PE can affect the
maternal liver, kidneys, brain and clotting system
and is often complicated with fetal growth restric-
tion (FGR) and preterm birth (PTB).
The internal body clock is of main importance in
the regulation of the metabolic and hormonal states
during reproduction and pregnancy (Andraweera
et al., 2013; Cha et al., 2012; Olcese, 2012;
Valenzuela et al., 2015). All tissues and cells, includ-
ing the placenta, have a circadian clock, which is kept
synchronous by the master clock (Balsalobre et al.,
1998; McNamara et al., 2001). The circadian clock
imposes 24-hour rhythmicity of behavior, physiol-
ogy, and metabolism. The mammalian circadian
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system is regulated by the circadian master clock,
located in the suprachiasmatic nuclei and receiving
light input from the retina to keep synchrony with
the light–dark cycle. Evidence is accumulating that
circadian misalignment significantly impacts preg-
nancy and health during the life course (Roenneberg
& Merrow, 2016). Recent reports, studying women
working night shifts (in services such as healthcare,
military, protection and airway), show associations
between disrupting the light–dark cycle during preg-
nancy and a higher risk of PTB, low birth weight,
spontaneous abortion and subfertility (Knutsson,
2003; Mahoney, 2010; Waddell et al., 2012). So far,
however, only a few data are available on associations
between alterations of the circadian rhythm and PE
(Ditisheim et al., 2013; Haelterman et al., 2007;
Mozurkewich et al., 2000; Wergeland & Strand,
1997). In this regard of interest is the hormone
melatonin, which is regulated by the circadian
clock and synthesized by the placenta thereby pro-
tecting against excessive oxidative stress involved in
the pathogenesis of PE (Chen et al., 2013; Hobson
et al., 2013; Valenzuela et al., 2015).
Epigenetic mechanisms implicated in fetal and pla-
cental development can explain associations between
PE and increased risks of features of noncommunic-
able diseases in mothers and children (Barker, 1993;
Gluckman et al., 2008; Hanson & Gluckman, 2008;
Jaddoe et al., 2014). Altered DNA methylation pat-
terns are found in placental tissues of PE and are
associated withmaternal blood pressure and excessive
oxidative stress (Kulkarni et al., 2011). Approximately
10% of the transcriptome is under circadian regula-
tion, and, at the molecular level, the circadian oscilla-
tor is composed of a set of clock genes that act in
interconnected transcription/translation feedback
loops (Panda et al., 2002; Panda et al., 2002; Zhang
et al., 2014) (see Figure 1 for a schematic overview of
the regulation of the molecular clock). ARNTL (also
known as BMAL1) and CLOCK are the positive acti-
vators and drive the transcription of clock genes by
binding to E-box elements on their promoters. PER
and CRY inhibit the specific transcription activation
by ARNTL and CLOCK, thereby forming a negative
feedback loop. An additional loop is formed by
NR1D1 (also known as Rev-Erbα), which represses
ARNTL transcription. The period length of the circa-
dian clock cycle is fine-tuned by posttranslational
modifications, such as phosphorylation and ubiquity-
lation, that regulate clock protein stability.
From this background, we hypothesize that PE is
associated with alterations in tissue-specific epigenetic
programming of circadian clock (controlled) gene loci
in placental and newborn tissues. The objective of our
Figure 1. Circadian clock. Model of the circadian core oscillator, showing the main core clock genes and transcription/translation
feedback loops, as well as clock (controlled) genes (CCGs) that link the molecular clock to oscillating output processes. The core clock
proteins are depicted as circles (CLOCK, ARNTL, CRY, PER, NR1D1).
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study was to examine the DNA methylation of circa-
dian clock and clock-controlled genes in the placenta,
umbilical cord leukocytes (UCL) and human umbili-
cal vein endothelial cells (HUVEC) in relation to PE.
Because of clear differences in pathophysiology, we
selected a group of early-onset PE (EOPE, onset <34
weeks of gestation) and late-onset PE (LOPE, onset
≥34 weeks of gestation) (Brown et al., 2013; Dekker
et al., 2014). In addition, because PE is often compli-
cated with FGR and PTB, conditions known to also
affect epigenetic programming, we investigated the
DNA methylation of PE in comparison with non-PE




A nested case–control study was conducted and
embedded in the Rotterdam Periconceptional
Cohort (Predict Study), a prospective tertiary hos-
pital-based study of the Department of Obstetrics
and Gynecology, Erasmus University Medical
Center, Rotterdam, the Netherlands (Steegers-
Theunissen et al., 2015). The study has been
approved by the local Medical Ethical and
Institutional Review Board of the Erasmus
University Medical Center (MEC-2004-227). At
enrolment, all participants signed written
informed consent before participation.
Patients with EOPE and LOPE were enrolled as
well as controls without PE (Figure 2). Controls
were divided into three different study groups:
uncomplicated controls and complicated controls
comprising of FGR and spontaneous PTB. The
rational is that EOPE often is accompanied with
adverse outcomes such as PTB and FGR, and
including these additional control groups provides
the opportunity to exclude confounding as much
as possible by gestational age and birth weight.
PE was defined as systolic blood pressure
≥140 mmHg or diastolic blood pressure
≥90 mmHg on at least two occasions 4 hours
apart after 20 weeks of gestation with proteinuria
(protein/creatinine ratio of ≥30 mg/mmol).
EOPE was defined as the onset of the disease
<34 weeks of gestation following the
International Society for the Study of
Hypertension in Pregnancy (ISSHP) guidelines
Figure 2. Flowchart of the study population. EOPE: early-onset preeclampsia; LOPE: late-onset preeclampsia; CTRL: uncomplicated
controls; FGR: fetal growth restriction; PTB: preterm birth; UCL: umbilical cord leukocytes; HUVEC: human umbilical vein endothelial cells.
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(Brown et al., 2013; Dekker et al., 2014). FGR
was defined as a birth weight below the 10th
percentile. Patients were included based on an
estimated fetal weight below the 10th percentile
of ultrasound measurements during pregnancy.
This was validated with a birth weight below
the 10th percentile according to the reference
curves of the Dutch Perinatal Registry.
Spontaneous PTB was defined as delivery <37
weeks of gestation. Uncomplicated controls were
pregnancies without PE, gestational hypertension,
FGR or spontaneous PTB. Clinical data were
obtained from medical records.
Sample collection and DNA extraction
UCL: Umbilical cord blood was collected in antic-
oagulant vacutainer tubes (ethylenediaminetetraa-
cetic acid) and processed within 48 hours after
delivery to determine white blood cell count and
differentiation and to store the isolated total white
blood cell pellets at ‒80°C until DNA extraction.
Prior to DNA extraction, thawed UCL were sub-
jected to erythrocyte lysis by use of Erythrocyte
Lysis Buffer (Qiagen, Hilden, Germany) according
to the manufacturer’s protocol.
Placental tissue: After removal of the mem-
branes and 2 mm of the top placental layer, pla-
cental biopsies (0.5 cm3) were taken at four
different sites of the fetal side of the placenta in a
radius of 3 cm around the umbilical cord inser-
tion. Samples were washed in phosphate buffered
saline solution (PBS), frozen in liquid nitrogen and
stored at −80°C until DNA extraction. Placental
tissue (30 mg) was grinded manually on dry ice.
The obtained frozen powder was immediately
added to lysis buffer and stored at −80°C until
further processing.
HUVEC: The umbilical cord vein was rinsed
with cord buffer once and all umbilical cord
blood was removed, filled with collagenase solu-
tion (1 mg/mL). After incubation for 15 min in a
PBS water bath (37°C), detached HUVEC were
obtained and purified by magnetic-activated cell
separation (MACS) with CD146 MACS
MicroBeads (Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany). HUVEC pellets were frozen
in liquid nitrogen and stored at −80°C until DNA
extraction.
The collection and storage process was done in
a standardized way by trained researchers.
Genomic DNAwas extracted from all tissues using
the Allprep DNA/RNA isolation mini kit (Qiagen,
Hilden, Germany), using themanufacturer’s protocol,
and quantified using absorbance spectrometry.
DNA methylation measurement and pathway-
driven gene selection
Isolated DNA (500 ng) was treated with sodium bisul-
fite using the EZ-96 DNA methylation kit (Shallow
Well Format) (Zymo Research, Irvine, CA). DNA
methylation was measured by using Illumina
HumanMethylation450K BeadChip. The methylation
module of GenomeStudio (Illumina Inc., San Diego,
CA) was used to check the performance of built-in
quality controls in the Control Dashboard. CpGs
located on the X-chromosome and CpGs containing
known single nucleotide polymorphisms were
excluded from analysis (Touleimat & Tost, 2012).
Data were normalized by using the Dasen procedure.
Methylation β-values were converted toM-values (M-
value = log2 [β-value/(1-β-value)]). To achieve a path-
way-driven analysis of DNA methylation at circadian
clock (controlled) gene loci, a total of 39 genes were
selected (Figure 3). This included core clock genes,
clock-controlled genes, as well as output genes.
Considering that PE is associated with metabolic
derangements, we especially focused on output genes
that are involved in metabolic processes or that have
been shown to have a linkwith the circadian clock and
metabolic queues, such as insulin or glucose levels
(Chaves et al., 2014; Lamia et al., 2009; O’Neill &
Reddy, 2011; Vanselow & Kramer, 2007). As shown
in Figure 3, for these 39 genes there are 939 CpGs
present in the Illumina 450K array. These CpGs are
distributed across the gene loci and are present in
CpG-islands around the transcription start, at gene
body and at regulatory regions such as the 5ʹ- and
3ʹ-UTR.
Statistical analysis
For statistical analysis of clinical characteristics,
analysis of variance (ANOVA) with post hoc
Dunnett t-test for pairwise comparisons was used
to compare continuous variables between experi-
mental groups. Chi-square or Fischer’s exact
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testing was used to compare categorical variables.
For skewed data Kruskal–Wallis with post hoc
Mann–Whitney tests were used.
To test for statistically differentially methylated
CpGs (DMCs) in EOPE and LOPE compared to
(un)complicated control groups, ANOVA and
analysis of covariance (ANCOVA) with post hoc
Bonferroni adjustment for multiple comparisons
were performed. Although we included sponta-
neous PTB as an additional control group, in the
ANCOVA model adjustments were made for
gestational age at delivery and batch effect.
Regarding UCL, adjustment for total number of
UCL (×109/L) was performed. This information
was available from flow-cytometric data of 61 sam-
ples (70%). Data imputation was used for missing
data on leukocyte counts. We considered results to
be statistically significant when p < 0.05. All sta-
tistical analyses were performed with R (R: A
language and Environment for Statistical
Computing, version 3.1.3, 2015 for Windows, R
Core Team, Vienna, Austria).
Results
Clinical characteristics
DNA methylation data were available of a total
of 114 pregnancies. Exclusion of two pregnan-
cies, which did not meet the inclusion criteria,
resulted in a total sample of 112 pregnancies,
consisting of 13 patients with EOPE, 16 patients
with LOPE, 36 uncomplicated controls, 27 preg-
nancies complicated by FGR and 20 by sponta-
neous PTB. In Table 1, maternal and newborn
characteristics are shown. In line with the selec-
tion criteria, blood pressure, gestational age and
birth weight differed between PE and (un)com-
plicated control groups. Patients with EOPE and
LOPE were more often nulliparous compared to
uncomplicated controls (respectively 84.6% and
81.3%, versus 30.6%, p = 0.001). In the EOPE
group, more pregnancies were terminated by
cesarean section compared to all other groups.
Regarding the newborn characteristics, there
were no significant differences in gender between
Figure 3. Selection of circadian clock and clock-controlled genes and CpGs. AKT1: gene; V-Akt: murine thymoma viral oncogene
homolog1; ARNTL: aryl hydrocarbon receptor nuclear translocator-like; ARNTL2: aryl hydrocarbon receptor nuclear translocator-like 2;
BHLHE40: basic helix-loop-helix family, member e40; BHLHE41: basic helix-loop-helix family, member e41; CLOCK: clock circadian
regulator; CRTC1: CREB-regulated transcription coactivator 1; CRY1: cryptochrome circadian clock 1; CRY2: cryptochrome circadian
clock 2; CSNK1E: casein kinase 1, epsilon; DBP: D site of albumin promoter (albumin D-box) binding protein; FGF21: fibroblast growth
factor 21; FOXO1: forkhead box O1; FOXO3: forkhead box O3; GSK3B: glycogen synthase kinase 3 beta; MAPK1: mitogen-activated
protein kinase 1; NPAS2: neuronal PAS domain protein 2; NR1D1: nuclear receptor subfamily 1, group D, member 1; NR1D2: nuclear
receptor subfamily 1, group D, member 2; PER1: period circadian clock 1; PER2: period circadian clock 2; PER3: period circadian clock
3; PRDX1: peroxiredoxin 1; PRDX2: peroxiredoxin 2; PRDX3: peroxiredoxin 3; PRDX5: peroxiredoxin 5; PRDX6: peroxiredoxin 6;
PRKAA1: protein kinase, amp-activated, alpha 1 catalytic subunit; PRKAB1: protein kinase, AMP-activated, beta 1 non-catalytic
subunit; PRKACA: protein kinase, CAMP-dependent, catalytic, alpha; PRKCA: protein kinase C, alpha; RORA: RAR-controlled orphan
receptor A; RORB: RAR-controlled orphan receptor B; RORC: RAR-controlled orphan receptor C; SIRT1: sirtuin 1; SIRT2: sirtuin 2;
STRA13: stimulated by retinoic acid 13; TIMELESS: timeless circadian clock; WEE1, WEE1 G2 checkpoint kinase.
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the study groups. Gestational age and birth
weight differed between all study groups.
Although gestational age was still lower in
EOPE compared to spontaneous PTB, these two
groups were most comparable in gestational age.
Identification of DMCs between all study groups
As shown in Figure 4, we found significant differ-
ences in CpG methylation of clock (controlled)
genes in all analyzed tissues. The number of
DMCs was tissue-specific and most DMCs were
found in UCL (n = 31), followed by placenta
(n = 7) and HUVEC (n = 1).
Comparisons of EOPE and LOPE versus (un)
complicated controls (Figure 5)
EOPE significantly differed from spontaneous PTB
at six clock (controlled) CpGs in placental tissue,
of the genes: AKT1 (p = 8.10E-5), BHLHE41
(p = 0.001), CSKN1E (p = 4.03E-5), PRDX1
(n = 2, p = 3.73E-5 and p = 0.016), and RORA
(p = 0.014). As shown in Figure 6, these CpGs
were hypomethylated in EOPE. In addition, in
EOPE compared with spontaneous PTB, 21 CpGs
were differentially methylated in UCL of the core
clock genes: ARNTL (p = 0.001), ARNTL2
(p = 0.022), CLOCK (p = 1.40E-4), CRY2 (n = 2,
p = 0.001 and p = 1.84E-4), PER2 (p = 7.72E-5),
NPAS2 (n = 4, 2.57E-4 < p < 0.035); and clock-
controlled genes: CSKN1E (p = 0.003), FGF21
(p = 4.15E-4), FOXO1 (p = 0.015), GSK3B
(p = 0.024), MAPK1 (p = 1.09E-5), PRDX5
(p = 0.003), PRKAA1 (p = 0.002), PRKCA (n = 3,
1.39E-5 < p < 3.89E-4) and RORA (p = 0.018). As
shown in Figure 6, most CpGs were hypermethy-
lated in EOPE.
In EOPE compared with FGR, we assessed two
DMCs in placental tissue of the genes: PER1
(p = 0.041) and PRDX1 (p = 0.001) and eight
DMCs were found in UCL in the same comparison
of groups of the core clock genes: CLOCK (p = 0.024)
and PER2 (p = 0.049); and clock-controlled genes:
CSKN1E (p = 0.007), FGF21 (p = 0.017), FOXO3
(p = 0.033), MAPK1 (p = 4.78E-5), PRDX5
(p = 0.044) and PRKCA (0.001).
EOPE differed from uncomplicated controls at
six circadian clock (controlled) CpGs in placental
tissue of the genes: AKT1 (p = 0.045), CRTC1
(p = 0.020), CSKN1E (p = 0.017), PER1
(p = 0.005), PRDX1 (1.36E-4) and RORA
(p = 0.033), and 11 DMCs were found in UCL in
the same comparison of groups of the core clock
genes: ARNTL2 (p = 0.009), CLOCK (p = 0.001),
CRY2 (n = 2, p = 0.009) and PER2 (p = 0.007), and
Table 1. Maternal and newborn characteristics.
Maternal characteristics (n = 112) EOPE (n = 13) LOPE (n = 16) Uncomplicated controls (n = 36) FGR (n = 27)
Spontaneous PTB
(n = 20)
Age (years) 30.0 ± 4.7 33.3 ± 4.5 31.8 ± 5.1 29.7 ± 6.0 31.0 ± 4.8
Nulliparous, n (%) 11 (84.6) 13 (81.2) 11 (30.6)*# 17 (63.0) 10 (50.0)
Peak systolic BP (mmHg) 169.5 ± 24.2 151.4 ± 11.8 125.7 ± 12.2*# 129.9 ± 14.3*# 124.9 ± 14.6*#
Peak diastolic BP (mmHg) 98.2 ± 19.1 93.9 ± 11.2 74.8 ± 7.5*# 76.8 ± 9.9*# 76.6 ± 13.1*#
Cesarean section, n (%) 11 (84.6) 5 (31.3)* 10 (27.8)* 9 (33.3)* 4 (20.0)*













Preconception BMI (kg/m2) 24.7 (10.1) 24.1 (4.4) 23.7 (4.8) 23.0 (6.5) 23.8 (6.1)
Smoking (yes), n (%) 2 (18.2) 0 (0.0) 0 (0.0) 2 (8.0) 2 (10.5)1
Comorbidity (yes), n (%) 2 (15.4) 10 (62.5) 19 (52.8) 11 (40.7) 8 (40.0)
Newborn characteristics
Male gender, n (%) 3 (23.1) 7 (43.8) 21 (58.3) 15 (55.6) 10 (50.0)
Gestational age at birtha (weeks) 30.7 (3.4) 37.4 (1.9)* 39.9 (1.9)*# 38.9 (2.6)* 35.4 (7.9)*#
Birth weighta (grams) 1185 (481) 3183 (1244)* 3713 (551)*# 2630 (595)*# 2660 (1805)*#
Birth weight <10th percentile, n (%) 1 (7.7) 3 (18.8) 0 (0.0)# 27 (100.0)*# 0 (0.0)#
Data represented as mean (± standard deviation) with corresponding ANOVA testing to examine overall differences between EOPE, LOPE,
uncomplicated controls, FGR and spontaneous PTB, followed by the post hoc Dunnett t-test for pairwise comparisons versus both EOPE and
LOPE. Data represented as number (%) with corresponding chi-square/Fischer’s exact testing.
aSkewed data represented as median (interquartile range) with corresponding Kruskal–Wallis testing and post hoc Mann–Whitney testing.
*p <0.05 versus EOPE pregnancies. # p <0.05 versus LOPE pregnancies.
ANOVA: analysis of variance; BP: blood pressure; BMI: body mass index; EOPE: early-onset preeclampsia; LOPE: late-onset preeclampsia; FGR: fetal
growth restriction; PTB: preterm birth.
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clock-controlled genes: FOXO3 (7.98E-5), MAPK1
(n = 2, p = 0.006 and p = 2.52E-6), PRDX5
(p = 0.002) and PRKCA (n = 2, p = 0.006 and
p = 0.005).
While in the overall analysis one DMC was
found in HUVEC, we found no DMCs in
HUVEC when comparing EOPE and LOPE to all
other study groups. This indicates that the DMCs
identified with the overall analysis represent dif-
ferences between control groups. Also no DMCs
were found in LOPE. In Figure 6, absolute methy-
lation levels are shown for the different groups at
different gestational ages.
Discussion
We established tissue-specific alterations in
methylation of circadian clock genes in EOPE
compared to uncomplicated controls, FGR and
spontaneous PTB, but not in any comparison
with LOPE. In EOPE compared to spontaneous
PTB, we identified in placental tissue DMCs in
circadian clock-controlled genes, but not in the
circadian core clock genes. In particular, the iden-
tification of DMCs in AKT1 and PRDX1 is in line
with the oxidative stress imbalance in the placenta
(Figure 1 shows the function of these genes).
However, in UCL we identified DMCs in the cir-
cadian core clock genes ARNTL, CLOCK (and
NPAS2, a CLOCK homolog in some tissues),
CRY2 and PER2 in EOPE compared to
spontaneous PTB. These genes are necessary for
circadian clock function and changes in expression
have been associated with noncommunicable dis-
eases, such as metabolic disease and cancer
(Barclay et al., 2012; Haus & Smolensky, 2013).
The most distinct differences were observed in
EOPE compared to spontaneous PTB. Gestational
age was most comparable between these two groups,
which strengthens the hypothesis that PE is asso-
ciated with differential methylation itself without
confounding by gestational age. This is clearly
demonstrated in the right part of Figure 6, where
absolute DNA methylation levels in EOPE, LOPE
and (un)complicated control groups are depicted at
the gestational age of sampling. No differential
methylation was observed between LOPE and all
other (complicated) control groups. The epigenetic
landscape is formed in particular during the pericon-
ceptional period and mainly during the first days
after conception, supporting the evidence that
LOPE largely develops after this period. The altera-
tions in methylation as a memory of exposures in
EOPE substantiate the first trimester origin of this
PE phenotype. EOPE and LOPE are likely to reflect
different underlying biological mechanisms, often
indicated as the placental versus the metabolic syn-
drome (Redman & Sargent, 2003).
Previous research showed that clock gene expres-
sion can be enhanced by hypoxia in human tropho-
blast cells in vitro (Frigato et al., 2009; Waddell et al.,
2012). Intermittent placental perfusion, caused by
Figure 4. Differentially methylated CpGs for the three different tissues. An overall ANOVA was performed to test for differentially
methylated CpGs (p < 0.05) between all study groups. UCL: umbilical cord leukocytes; HUVEC: human umbilical vein endothelial cells.
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deficient trophoblast invasion of the endometrial
arteries, can result in hypoxia-reoxygenation injury.
The fluctuation in oxygen concentrations can cause
excessive placental oxidative stress and as such alter
the establishment of the epigenetic methylation mar-
kers (Hung & Burton, 2006). This is in line with our
Figure 5. EOPE and LOPE compared to different control groups (ANCOVA). ANCOVA, adjusted for gestational age at delivery, batch
effect, and leukocyte count for UCL only was performed. p Values are shown in the columns. EOPE: early-onset preeclampsia; LOPE:
late-onset preeclampsia; CTRL: uncomplicated controls; FGR: fetal growth restriction; PTB: preterm birth; UCL: umbilical cord
leukocytes; HUVEC: human umbilical vein endothelial cells; n.s.: not significant.
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finding that in EOPE most DMCs were hypomethy-
lated in placental tissue and hypermethylated inUCL
and substantiated by other epigenetic studies of can-
didate genes in PE (Anton et al., 2014; Blair et al.,
2013; Hogg et al., 2013; Sundrani et al., 2013; Yuen
et al., 2010). The opposite direction of methylation in
placental tissue and UCL might be explained by
differences in tissue sensitivity and the level of
exposure. Although an important question is
whether the observed changes in DNA methylation
result in changes in gene expression, the current data
cannot answer this question. Nevertheless, it is note-
worthy that the same type of CpGs within a gene (i.e.
promoter, body) show methylation changes in the
same direction as the identified DMCs, although the
differences are not significant (not shown).
Figure 6. Absolute DNA methylation levels in the EOPE, LOPE and (un)complicated control groups depicted at the gestational age of
delivery. EOPE: early-onset preeclampsia; LOPE: late-onset preeclampsia; CTRL: uncomplicated controls; FGR: fetal growth restriction;
PTB: preterm birth. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 1E-4, *****p < 1E-5.
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Although DNA methylation is considered to be
mostly stable, there is a recent study showing that
a number of CpGs show circadian oscillation in
DNA methylation in mouse liver (Vollmers et al.,
2012). In order to exclude a possible effect of the
time of delivery, we performed an additional sta-
tistical analysis in which we did a sensitivity ana-
lysis for the time of delivery (supplemental figure,
Figure S1). This did not affect the majority of the
DMCs identified in the present study, indicating
that time of delivery is not a confounding factor in
our study.
Epigenetics and health of the offspring
In this study, we hypothesized that PE may be asso-
ciated with changes in DNA methylation of circadian
clock gene loci and leave epigenetic marks during
pregnancy in newborn tissues. Alterations in DNA
methylation of circadian clock and clock-controlled
genes may be a consequence of a situation of excessive
oxidative stress during exposure to this disorder.
However, either cause or consequence, we showed in
this study that an alteredmethylation level was present
in some clock (controlled) genes in placental and fetal
tissues after EOPE. This suggests that the epigenome
of EOPE offspring might be affected as well. This is
supported by our observation that differential methy-
lation is higher in UCL than in placenta, suggesting
that the alterations observed in placenta further
induced epigenetic alterations in UCL (as a conse-
quence of an imbalanced cellular environment due
to placental malfunctioning and excessive oxidative
stress). This is in line with the Developmental Origins
of Health and Disease (DOHaD) paradigm (Barker,
1993). Unfortunately, we were not able to study DNA
methylation of the offspring after follow-up. For
future research, it is essential to validate these findings
with data of the transcriptome and subsequently to
measure DNA methylation and expression levels in
these children and monitor the functioning of their
circadian clock.
Strengths and limitations
As far as we know, this is the first study investigat-
ing DNA methylation of circadian clock-con-
trolled genes in unique homogeneous study
groups of EOPE and LOPE cases, and spontaneous
PTB, FGR and uncomplicated controls. We were
able to study three different tissues in most preg-
nancies collected in a standardized and high-qual-
ity manner. The external validity of the study is
limited which is inherent to the tertiary hospital
setting in which the study was performed.
Moreover, the small number of samples, in parti-
cular of HUVEC, and the heterogeneity of cell
types in placental tissues remain issues of potential
bias (Grigoriu et al., 2011; Joo et al., 2013).
Another limitation is that we do not have infor-
mation about the circadian clock and light expo-
sure of the participants to test for correlations with
the results.
Conclusion
DNAmethylation status of circadian clock and clock-
controlled genes in placental tissue and UCL is differ-
ent between patients with EOPE and non-PE controls.
This may be explained by a longer exposure to pla-
cental oxidative stress as compared to pregnancies
complicated by LOPE. For future research, it would
be interesting to study whether these DNA methyla-
tion alterations affect long-term health and circadian
performance in the offspring.
Condensation and short version of title
Only EOPE is associated with variations in DNA methylation
of circadian clock and clock-controlled genes in placental
tissue, and UCL.
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